Categories AlphaGraphs, Cannabis, Earnings

Infographic: Highlights of Cronos’ (CRON) Q4 2021 earnings report

Cronos Group Inc. (NASDAQ: CRON) has reported a wider net loss for the fourth quarter of 2021, despite a double-digit increase in revenues. The bottom line was impacted by a sharp increase in operating expenses.

The Canada-based cannabis producer reported a comprehensive net loss of $132.7 million or $0.36 per share for the fourth quarter, compared to a loss of $60.4 million or $0.31 per share last year.  

On the other hand, net revenues increased 51% year-over-year to $25.7 million, supported by continued growth in the sales of adult-use cannabis outside the U.S., especially in Canada and Israel.

“Our fourth quarter 2021 results indicate positive momentum, which we will look to carry forward as we begin to implement our strategic and operational realignment initiatives. As we look to 2022, we will continue to realign Cronos Group’s organizational structure to match our strategy, with a primary focus on adult-use products and elevating our brands through rare cannabinoids,” said Kurt Schmidt, chief executive officer of Cronos Group.

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu

Trxade Health Inc. (NASDAQ: MEDS) is an online pharmaceutical marketplace that provides a platform for independent pharmacies to operate more effectively. The company’s digital platform helps optimize drug procurement and

AMAT Stock: Is now the right time to invest in Applied Materials?

It is estimated that the size of the global chip manufacturing equipment market would nearly double from the current levels to about $142 billion in the next eight years. Applied

Here’s a look at Take-Two Interactive Software’s (TTWO) expectations for the coming year

Shares of Take-Two Interactive Software (NASDAQ: TTWO) were down over 2% on Friday. The stock has dropped 32% year-to-date and 35% over the past 12 months. Earlier this week, the

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top